The grades of 8 Biotechnology stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
Intrexon Corporation (XON) gets a higher grade this week, advancing from a C last week to a B. The company also gets A’s in sales growth and earnings surprise. For more information, get Portfolio Grader’s complete analysis of XON stock.
ImmuCell Corporation (ICCC) improves from a C to a B rating this week. ImmuCell Corporation is engaged in the development, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industry. The company also gets A’s in sales growth. For more information, get Portfolio Grader’s complete analysis of ICCC stock.
This is a strong week for Minerva Neurosciences Inc (NERV). The company’s rating climbs to B from the previous week’s C. The company also gets A’s in earnings revisions and earnings momentum. For more information, get Portfolio Grader’s complete analysis of NERV stock.
This week, Vericel Corporation’s (VCEL) ratings are up from a D last week to a B. For more information, get Portfolio Grader’s complete analysis of VCEL stock.
Fortress Biotech, Inc. (FBIO) shows solid improvement this week. The company’s rating rises from a C to a B. The company also gets A’s in earnings surprise. For more information, get Portfolio Grader’s complete analysis of FBIO stock.
Abeona Therapeutics, Inc. (ABEO) boosts its rating from a C to a B this week. The company also gets A’s in earnings momentum. For more information, get Portfolio Grader’s complete analysis of ABEO stock.
The rating of NanoViricides, Inc. (NNVC) moves up this week, rising from a C to a B. For more information, get Portfolio Grader’s complete analysis of NNVC stock.
AVEO Pharmaceuticals, Inc. (AVEO) earns a B this week, jumping up from last week’s grade of C. AVEO Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapeutics. The company also gets A’s in sales growth and earnings momentum. For more information, get Portfolio Grader’s complete analysis of AVEO stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
